Clinical Trial Update: QUILT-3.033: Haplo NK With SQ ALT-803 for Adults With Relapsed or Refractory AML [Phase 2]

View source ↗

Summary

Phase 2 trial update for haploidentical NK cells with ALT-803 in adults with relapsed or refractory acute myeloid leukemia has completed with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• ALT-803 (Interleukin-15 super-agonist)
• Haplo NK

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2020-11-27